Alan McShane
Nessuna posizione attualmente
Profilo
Alan McShane served as the Director of the Intensive Care Unit at St. Vincent's University Hospital and as a Non-Executive Director at Sublimity Therapeutics Ltd.
He earned a doctorate degree from University College Dublin in 1976.
Precedenti posizioni note di Alan McShane
| Società | Posizione | Fine |
|---|---|---|
St. Vincent's University Hospital
 St. Vincent's University Hospital Hospital/Nursing ManagementHealth Services St. Vincent's University Hospital operates as a teaching hospital. It provides front line, acute, chronic and emergency care services. The company was founded by Mary Aikenhead in April, 1835 and is headquartered in Dublin, Ireland. | Corporate Officer/Principal | - |
Sublimity Therapeutics Ltd.
 Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sublimity Therapeutics Ltd. develops and manufactures pharmaceutical products. It engages in the development of gastrointestinal and immunological therapeutics. The firm’s lead product, CyCol, harnesses the powerful efficacy of the known immunosuppressive drug, cyclosporine in a safer format by targeting drug release towards the site of diseased tissue in the colon of patients with ulcerative colitis. Its other products include CyCron, AlloCol, CyLow, oral vaccines and oral peptides. The company was founded by Ivan Coulter in 2003 and is headquartered in Dublin, Ireland. | Direttore/Membro del Consiglio | - |
Formazione di Alan McShane
| University College Dublin | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
St. Vincent's University Hospital
St. Vincent's University Hospital Hospital/Nursing ManagementHealth Services St. Vincent's University Hospital operates as a teaching hospital. It provides front line, acute, chronic and emergency care services. The company was founded by Mary Aikenhead in April, 1835 and is headquartered in Dublin, Ireland. | Health Services |
Sublimity Therapeutics Ltd.
Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sublimity Therapeutics Ltd. develops and manufactures pharmaceutical products. It engages in the development of gastrointestinal and immunological therapeutics. The firm’s lead product, CyCol, harnesses the powerful efficacy of the known immunosuppressive drug, cyclosporine in a safer format by targeting drug release towards the site of diseased tissue in the colon of patients with ulcerative colitis. Its other products include CyCron, AlloCol, CyLow, oral vaccines and oral peptides. The company was founded by Ivan Coulter in 2003 and is headquartered in Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- Alan McShane
